BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15567950)

  • 1. [Classical Hodgkin's lymphoma: biology and grey zones].
    Gaulard P; Brousse N
    Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiopathology of Hodgkin's disease].
    Gaulard P; Kanavaros P
    Rev Prat; 1998 May; 48(10):1065-9. PubMed ID: 9781149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
    Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
    Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in malignant lymphomas: review and prospective evaluation.
    Hsu SM; Waldron JW; Hsu PL; Hough AJ
    Hum Pathol; 1993 Oct; 24(10):1040-57. PubMed ID: 8406414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
    Schmidt U; Metz KA; Leder LD
    Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).
    Rüdiger T; Jaffe ES; Delsol G; deWolf-Peeters C; Gascoyne RD; Georgii A; Harris NL; Kadin ME; MacLennan KA; Poppema S; Stein H; Weiss LE; Müller-Hermelink HK
    Ann Oncol; 1998; 9 Suppl 5():S31-8. PubMed ID: 9926235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.
    Asano N; Kinoshita T; Tamaru J; Ohshima K; Yoshino T; Niitsu N; Tsukamoto N; Hirabayashi K; Izutsu K; Taniwaki M; Morishima Y; Nakamura S
    Haematologica; 2011 Nov; 96(11):1636-43. PubMed ID: 21859738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological diagnosis of Hodgkin's disease].
    Delsol G
    Rev Prat; 1998 May; 48(10):1060-4. PubMed ID: 9781148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
    De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
    Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
    Carbonnelle A; Delarue R; Canioni D; Brousse N
    Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease.
    Van Gool SW; Delabie J; Vandenberghe P; Coorevits L; De Wolf-Peeters C; Ceuppens JL
    Leukemia; 1997 Jun; 11(6):846-51. PubMed ID: 9177439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
    Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
    N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
    Hansmann ML; Küppers R
    Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.